Roche Holding AG (SWX:ROP)
328.50
+3.20 (0.98%)
Jun 12, 2026, 11:40 AM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
613.62K CHF
Profits / Employee
124.75K CHF
Market Cap
259.40B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Sandoz Group AG | 22,356 |
| Lonza Group AG | 20,000 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,821 |
| Galenica AG | 8,427 |
| Galderma Group AG | 7,676 |
Roche Holding AG News
- 21 hours ago - OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit - TheFly
- 1 day ago - Genentech granted priority review for Tecentriq Hybreza combination - TheFly
- 1 day ago - Roche announces EU IVDR approval of several Ventana label expansions - TheFly
- 1 day ago - FDA Grants Priority Review for Genentech's Tecentriq for a Certain Type of Stage III Colon Cancer - Business Wire
- 1 day ago - Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - PRNewsWire
- 1 day ago - FDA grants Priority Review for Roche's Tecentriq for a certain type of stage III colon cancer - GlobeNewsWire
- 3 days ago - Roche sticks to German investment after Eli Lilly cuts - Reuters
- 3 days ago - Roche Holding AG Transcript: Study update - Transcripts